PMC:7441788 / 20204-20639
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T111 | 192-203 | Body_part | denotes | nasopharynx | http://purl.org/sig/ont/fma/fma54878 |
| T112 | 279-290 | Body_part | denotes | nasopharynx | http://purl.org/sig/ont/fma/fma54878 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T10 | 192-203 | Body_part | denotes | nasopharynx | http://purl.obolibrary.org/obo/UBERON_0001728 |
| T11 | 279-290 | Body_part | denotes | nasopharynx | http://purl.obolibrary.org/obo/UBERON_0001728 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T247 | 44-49 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T248 | 120-132 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T249 | 345-350 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-sample-MedDRA
| Id | Subject | Object | Predicate | Lexical cue | meddra_id |
|---|---|---|---|---|---|
| T12 | 204-214 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | viral load | http://purl.bioontology.org/ontology/MEDDRA/10062178 |
| T13 | 291-301 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | viral load | http://purl.bioontology.org/ontology/MEDDRA/10062178 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T139 | 120-132 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T151 | 0-19 | Sentence | denotes | Gautret et al [58]. |
| T152 | 20-263 | Sentence | denotes | Observational study HCQ group: n = 80; no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly. |
| T153 | 264-302 | Sentence | denotes | Observation of nasopharynx viral load. |
| T154 | 303-387 | Sentence | denotes | Observational study design and no control group; No clinical outcomes were analyzed. |
| T155 | 388-435 | Sentence | denotes | Possible confounding factors were not adjusted. |
LitCovid-sample-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T9 | 192-203 | Body_part | denotes | nasopharynx | http://purl.obolibrary.org/obo/UBERON_0001728 |
| T10 | 279-290 | Body_part | denotes | nasopharynx | http://purl.obolibrary.org/obo/UBERON_0001728 |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T110 | 192-203 | Body_part | denotes | nasopharynx | http://purl.org/sig/ont/fma/fma54878 |
| T111 | 279-290 | Body_part | denotes | nasopharynx | http://purl.org/sig/ont/fma/fma54878 |
LitCovid-sample-PD-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 192-203 | http://purl.obolibrary.org/obo/MAT_0000447 | denotes | nasopharynx |
| T7 | 279-290 | http://purl.obolibrary.org/obo/MAT_0000447 | denotes | nasopharynx |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T151 | 0-19 | Sentence | denotes | Gautret et al [58]. |
| T152 | 20-263 | Sentence | denotes | Observational study HCQ group: n = 80; no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly. |
| T153 | 264-302 | Sentence | denotes | Observation of nasopharynx viral load. |
| T154 | 303-387 | Sentence | denotes | Observational study design and no control group; No clinical outcomes were analyzed. |
| T155 | 388-435 | Sentence | denotes | Possible confounding factors were not adjusted. |